[1] 宋敏,陆普选,方伟军,等.2022年WHO全球结核病报告:全球与中国关键数据分析[J/CD].新发传染病电子杂志,2023,8(1):87-92. [2] 中国防痨协会. 非活动性肺结核诊断及预防发病专家共识[J]. 结核与肺部疾病杂志, 2021, 2(3):197-201. [3] 国家感染性疾病临床医学研究中心, 深圳市第三人民医院,《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识[J]. 中国防痨杂志, 2020, 42(4):301-307. [4] 中华人民共和国国家卫生和计划生育委员会.结核病分类(WS196—2017)[J/CD].新发传染病电子杂志,2018,3(3):191-192. [5] COHEN A, MATHIASEN VD, SCHÖN T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis[J]. Eur Respir J, 2019, 54(3):1900655. [6] 王会珂, 罗茜, 魏千, 等. 基于炎症-免疫-营养评分和循环肿瘤细胞对食管癌根治术后患者构建预后列线图[J].中华肿瘤防治杂志, 2023, 30(4):225-238. [7] GAO L, ZHANG H, XIN H, et al.Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study[J]. Eur Respir J, 2018, 52(6):245-247. [8] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS 288—2017)[J/CD].新发传染病电子杂志,2018,3(1):59-61. [9] 邓国防, 路希维. 肺结核活动性判断规范及临床应用专家共识[J].中国防痨杂志, 2020, 42(4):301-307. [10] JACOBSON KR.Tuberculosis[J]. Ann Internal Med, 2017, 166(3):1245-1250 [11] LEE HN, KIM JI, KIM YH.Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis[J].PLoS One, 2021, 16(5):e0250616. [12] LUO Y, XUE Y, LIN Q, et al.Combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection[J]. Inter J Infect Dis, 2020, 8(97):190-196. [13] LUO Y, XUE Y, SONG H, et al.Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection[J]. J Infect, 2022, 84(5):648-657. [14] LY TDA, HOLI-JAMOVSKI F, HOANG VT, et al.Screening Strategy of Active Pulmonary Tuberculosis in Sheltered Homeless People in Marseille, 2019[J]. J Epidemiol Glob Health, 2021, 11(1):124-131. [15] UCHIDA Y, SOEJIMA K.Clinical characteristics of patients simultaneously diagnosed with lung cancer and active pulmonary tuberculosis in countries where tuberculosis is moderately endemic[J]. Transl Cancer Res, 2022, 11(8): 2480-2482. [16] YU Q, WENG WJ, LUO H, et al.The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients[J]. Infect Drug Resist, 2022, 15(8):4529-4539. |